106 related articles for article (PubMed ID: 26539495)
1. Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden.
Thorstenson A; Harmenberg U; Lindblad P; Holmström B; Lundstam S; Ljungberg B
Biomed Res Int; 2015; 2015():456040. PubMed ID: 26539495
[TBL] [Abstract][Full Text] [Related]
2. Impact of quality indicators on adherence to National and European guidelines for renal cell carcinoma.
Thorstenson A; Harmenberg U; Lindblad P; Ljungberg B; Lundstam S;
Scand J Urol; 2016; 50(1):2-8. PubMed ID: 26202573
[TBL] [Abstract][Full Text] [Related]
3. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005-2010: a population-based study from the national Swedish kidney cancer register.
Thorstenson A; Bergman M; Scherman-Plogell AH; Hosseinnia S; Ljungberg B; Adolfsson J; Lundstam S
Scand J Urol; 2014 Jun; 48(3):231-8. PubMed ID: 24666102
[TBL] [Abstract][Full Text] [Related]
4. Assessment of surgical margins in renal cell carcinoma after nephron sparing: a comparative study: laparoscopy vs open surgery.
Porpiglia F; Fiori C; Terrone C; Bollito E; Fontana D; Scarpa RM
J Urol; 2005 Apr; 173(4):1098-101. PubMed ID: 15758709
[TBL] [Abstract][Full Text] [Related]
5. Oncological outcomes of nephron sparing nephrectomy. 17-year analysis.
Aguilera Bazan A; Bañuelos B; Alonso-Dorrego JM; Diez J; Cisneros J; De la Peña Barthel J
Arch Esp Urol; 2014 Apr; 67(3):237-42. PubMed ID: 24840588
[TBL] [Abstract][Full Text] [Related]
6. The value of nephron-sparing surgery for the treatment of renal cell carcinoma 4 to 7 cm in size.
Pertia A; Managadze L; Chkhotua A
Georgian Med News; 2012 Nov; (212):7-12. PubMed ID: 23221132
[TBL] [Abstract][Full Text] [Related]
7. Elective nephron sparing surgery should become standard treatment for small unilateral renal cell carcinoma: Long-term survival data of 216 patients.
Becker F; Siemer S; Humke U; Hack M; Ziegler M; Stöckle M
Eur Urol; 2006 Feb; 49(2):308-13. PubMed ID: 16359779
[TBL] [Abstract][Full Text] [Related]
8. Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
Hellenthal NJ; Mansour AM; Hayn MH; Schwaab T
Urol Oncol; 2013 Jan; 31(1):36-41. PubMed ID: 21396834
[TBL] [Abstract][Full Text] [Related]
9. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
10. Preservation surgery in patients with localized renal cell cancer--nephron sparing surgery.
Djozić J; Djozić S; Bogdanović J; Sekulić V; Djozić M; Vojinov S; Levakov I; Zivojinov S; Jeremić D; Marušić G; Djozić D
Acta Chir Iugosl; 2014; 61(1):45-9. PubMed ID: 25782225
[TBL] [Abstract][Full Text] [Related]
11. Practice patterns for the surgical treatment of T1 renal cell carcinoma: a nationwide population-based register study.
Ljungberg B; Gudmundsson E; Christensen S; Lundstam S;
Scand J Urol; 2014 Oct; 48(5):445-52. PubMed ID: 24666103
[TBL] [Abstract][Full Text] [Related]
12. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
[TBL] [Abstract][Full Text] [Related]
13. A prospective, randomised EORTC intergroup phase 3 study comparing the oncologic outcome of elective nephron-sparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
Van Poppel H; Da Pozzo L; Albrecht W; Matveev V; Bono A; Borkowski A; Colombel M; Klotz L; Skinner E; Keane T; Marreaud S; Collette S; Sylvester R
Eur Urol; 2011 Apr; 59(4):543-52. PubMed ID: 21186077
[TBL] [Abstract][Full Text] [Related]
14. [Local recurrence of the renal cell carcinoma in renal fossa after complete radical nephrectomy. What are the risk factors?].
Ormanov D; Kirilov S; Ianev K; Georgiev M; Simeonov P; Dimitrov P; Bonev K; Vasilev V; Mavrov Kh; Panchev P
Khirurgiia (Sofiia); 2008; (1-2):34-6. PubMed ID: 18983006
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.
Morgan MA; Roberts NR; Pino LA; Trabulsi EJ; Brown DB; Gomella LG; Lallas CD
Can J Urol; 2013 Oct; 20(5):6933-7. PubMed ID: 24128832
[TBL] [Abstract][Full Text] [Related]
16. Disease outcome in patients with low stage renal cell carcinoma treated with nephron sparing or radical surgery.
Lerner SE; Hawkins CA; Blute ML; Grabner A; Wollan PC; Eickholt JT; Zincke H
J Urol; 1996 Jun; 155(6):1868-73. PubMed ID: 8618276
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of the 1997 TNM classification system for renal cell carcinoma.
Elmore JM; Kadesky KT; Koeneman KS; Sagalowsky AI
Cancer; 2003 Dec; 98(11):2329-34. PubMed ID: 14635066
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors influencing long-term survival of patients undergoing nephron-sparing surgery for nonmetastatic renal-cell carcinoma (RCC) with imperative indications.
Haferkamp A; Kurosch M; Pritsch M; Hatiboglu G; Macher-Goeppinger S; Pfitzenmaier J; Pahernik S; Wagener N; Hohenfellner M
Ann Surg Oncol; 2010 Feb; 17(2):544-51. PubMed ID: 19953334
[TBL] [Abstract][Full Text] [Related]
19. Hilar location is an independent prognostic factor for recurrence in T1 renal cell carcinoma after nephrectomy.
Shim M; Song C; Park S; Kim A; Choi SK; Kim CS; Ahn H
Ann Surg Oncol; 2015 Jan; 22(1):344-50. PubMed ID: 25323469
[TBL] [Abstract][Full Text] [Related]
20. Management and extended outcome of patients with synchronous bilateral solid renal neoplasms in the absence of von Hippel-Lindau disease.
Blute ML; Amling CL; Bryant SC; Zincke H
Mayo Clin Proc; 2000 Oct; 75(10):1020-6. PubMed ID: 11040850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]